INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
If AstraZeneca will not conduct a product recall on its SARS-CoV-2 injections, MHRA must demand it

If AstraZeneca will not conduct a product recall on its SARS-CoV-2 injections, MHRA must demand it

Then the house of cards will tumble, globally

Hedley Rees's avatar
Hedley Rees
May 13, 2024
∙ Paid
11

Share this post

INSIDE PHARMA
INSIDE PHARMA
If AstraZeneca will not conduct a product recall on its SARS-CoV-2 injections, MHRA must demand it
4
Share

Share

I posted this yesterday:

WHY BIG PHARMA IS DEAD IN THE WATER—GET READY TO STEP-UP TO THE PLATE

WHY BIG PHARMA IS DEAD IN THE WATER—GET READY TO STEP-UP TO THE PLATE

Hedley Rees
·
May 12, 2024
Read full story

It concluded:

THE OMG—WHO WILL CLEAR UP THE MESS?

I left you to mull over this:

Regulatory authorities once had the skills and experience to demand and coordinate remediation action, but not any more. The good guys have left, sadly.

Irrespective of their lack of skills, MHRA is still accountable.

What is the mess?

The mess is

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share